-
GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress
[ad_1] 80% Survival in Nonhuman Primates Observed in a Lethal Challenge Model ATLANTA, GA – (NewMediaWire) – November 30, 2023 – GeoVax…
Read More » -
Breaking
Navigating the Impact of a Strong U.S. Labor Market
With the unemployment rate holding steady at 3.7%, businesses continue to hire at a rapid pace, driven by strong consumer…
Read More » -
EF Hutton Completes Acquisition of Broker-Dealer Benchmark Investments, LLC
[ad_1] “When EF Hutton Talks, People Listen” NEW YORK, NY – (NewMediaWire) – November 30, 2023 – EF Hutton, an…
Read More » -
US Nuclear Corp. Announces Third Quarter 2023 Results
[ad_1] LOS ANGELES, CA – (NewMediaWire) – November 29, 2023 – US Nuclear Corp. (OTC-QB: UCLE), a leading manufacturer of…
Read More » -
GeoVax to Participate in Upcoming December Investor Events
[ad_1] ATLANTA, GA – (NewMediaWire) – November 29, 2023 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies…
Read More »